chr8-123437300-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018024.3(NTAQ1):āc.474G>Cā(p.Glu158Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000195 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018024.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NTAQ1 | NM_018024.3 | c.474G>C | p.Glu158Asp | missense_variant | 5/6 | ENST00000287387.7 | NP_060494.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NTAQ1 | ENST00000287387.7 | c.474G>C | p.Glu158Asp | missense_variant | 5/6 | 1 | NM_018024.3 | ENSP00000287387.2 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000275 AC: 69AN: 251178Hom.: 1 AF XY: 0.000214 AC XY: 29AN XY: 135806
GnomAD4 exome AF: 0.000186 AC: 272AN: 1461772Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 137AN XY: 727198
GnomAD4 genome AF: 0.000276 AC: 42AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2023 | The c.474G>C (p.E158D) alteration is located in exon 5 (coding exon 5) of the WDYHV1 gene. This alteration results from a G to C substitution at nucleotide position 474, causing the glutamic acid (E) at amino acid position 158 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at